FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs StimRelieve Migraine Device Trial

[ Price : $8.95]

FDA approves a StimRelieve IDE to launch a clinical trial of what the company describes as the worlds smallest percutaneously impl...

FDA Approves Merckֹs Bridion

[ Price : $8.95]

FDA approves a Merck NDA for Bridion (sugammadex) injection for reversing the effects of neuromuscular blockade induced by rocuron...

FDA Clears Viatom Techs Vital Sign Tracker

[ Price : $8.95]

FDA clears a Viatom Technologies 510(k) for the Checkme Pro, a connected medical device that tracks a number of vital signs.

New Import System Goes Online in February

[ Price : $8.95]

FDA says importers and brokers of agency-regulated products will need to begin using a joint FDA/Customs import system 2/28/2016.

Panel to Discuss Leadless Cardiac Pacemakers

[ Price : $8.95]

Federal Register Notice: FDAs Circulatory System Devices Panel will meet 2/18/16 to discuss leadless cardiac pacemaker device tech...

Pervasive Under-reporting at ClinicalTrials.gov: Report

[ Price : $8.95]

A STAT investigative report finds pervasive clinical trial reporting violations occurring across industry, researchers, academia, ...

FDA Clears LC Bead LUMI Radiopaque Beads

[ Price : $8.95]

FDA clears a BTG plc 510(k) for LC Bead LUMI, a radiopaque embolic bead for the embolization of hypervascular tumors and arteriove...

FDA Draft Guide on Head Lice Drug Development

[ Price : $8.95]

FDA releases a draft guidance on Head Lice Infestation: Developing Drugs for Topical Treatment that recommends clinical trial desi...

Reciprocal Approval Bill to Speed Access to Therapies: Cruz

[ Price : $8.95]

Senators Ted Cruz (R-TX) and Mike Lee (R-UT) introduce the Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act (S. 23...

FDA Needs to Publish Promised Biosimilar Guidance: Health Affairs

[ Price : $8.95]

A Health Affairs review of how FDA has implemented the biosimilars pathway finds a few issues still needing the agencys attention....